Why the study?
Pulmonary hypertension is associated with significant perioperative morbidity and mortality, but whether composite PAH risk scores adjusted for procedural risk can estimate perioperative risk was unknown.
Does a composite PAH risk assessment score adjusted for procedural risk accurately estimate perioperative risk in patients with pulmonary hypertension undergoing noncardiac surgery?
Does a composite PAH risk assessment score adjusted for procedural risk accurately estimate perioperative risk in patients with pulmonary hypertension undergoing noncardiac surgery?
A novel pulmonary hypertension perioperative risk (PHPR) score combining patient-level risk parameters and procedural risk can effectively stratify the risk of 30-day mortality or serious complications in patients with pulmonary hypertension undergoing noncardiac surgery.
Supports cautious use of PAH scores for perioperative planning in PH; leaves open need for prospective validation.
RATIONALE: Pulmonary hypertension (PH) is associated with significant perioperative morbidity and mortality. We hypothesised that pulmonary arterial hypertension (PAH) composite risk assessment scores could estimate perioperative risk for PH patients when adjusted for inherent procedural risk. METHODS: We identified patients in the Johns Hopkins PH Center Registry that had noncardiac surgery (including endoscopies) between September 2015 and January 2020. We collected information on preoperative patient-level and procedural variables and used logistic regression to evaluate associations with a composite outcome of death within 30 days or serious postoperative complication. We generated composite patient-level risk assessment scores for each subject and used logistic regression to estimate the association with adverse surgical outcomes. We adjusted multivariable models for inherent procedural risk of major cardiovascular events and used these models to generate a numerical PH perioperative risk (PHPR) score. RESULTS: Among 150 subjects, 19 (12.7%) reached the primary outcome, including 7 deaths (4.7%). Individual patient-level and procedural variables were associated with the primary outcome (all p<0.05). A composite patient-level risk assessment score built on three noninvasive parameters was strongly associated with reduced risk for poor outcomes (OR=0.4, p=0.03). This association was strengthened after adjusting the model for procedural risk. A PHPR score derived from the multivariable model stratified patients into low (0%), intermediate (≤10%), or high (>10%) risk of reaching the primary outcome. CONCLUSION: Composite PAH risk assessment scores can predict perioperative risk for PH patients after accounting for inherent procedural risk. Validation of the PHPR score in a multicentre, prospective cohort is warranted.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: